92 related articles for article (PubMed ID: 9654140)
1. Biochemical characterization of HIV-1 Rev as a potent activator of casein kinase II in vitro.
Ohtsuki K; Maekawa T; Harada S; Karino A; Morikawa Y; Ito M
FEBS Lett; 1998 May; 428(3):235-40. PubMed ID: 9654140
[TBL] [Abstract][Full Text] [Related]
2. Unique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 ('casein kinase-2').
Marin O; Sarno S; Boschetti M; Pagano MA; Meggio F; Ciminale V; D'Agostino DM; Pinna LA
FEBS Lett; 2000 Sep; 481(1):63-7. PubMed ID: 10984616
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of casein kinase II as a protein kinase responsible for stimulation of HIV-1 protease in vitro.
Haneda E; Furuya T; Asai S; Morikawa Y; Ohtsuki K
Biochem Biophys Res Commun; 2000 Aug; 275(2):434-9. PubMed ID: 10964683
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of HIV-1 Rev protein: implication of protein kinase CK2 and pro-directed kinases.
Meggio F; D'Agostino DM; Ciminale V; Chieco-Bianchi L; Pinna LA
Biochem Biophys Res Commun; 1996 Sep; 226(2):547-54. PubMed ID: 8806671
[TBL] [Abstract][Full Text] [Related]
5. Casein kinase II (CK-II)-mediated stimulation of HIV-1 reverse transcriptase activity and characterization of selective inhibitors in vitro.
Harada S; Haneda E; Maekawa T; Morikawa Y; Funayama S; Nagata N; Ohtsuki K; Nagata N; Ohtsuki K
Biol Pharm Bull; 1999 Oct; 22(10):1122-6. PubMed ID: 10549869
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of recombinant HIV-1 reverse transcriptase (rRT) as a glycyrrhizin-binding protein and the CK-II-mediated stimulation of rRT activity potently inhibited by glycyrrhetinic acid derivative.
Harada S; Maekawa T; Haneda E; Morikawa Y; Nagata N; Ohtsuki K
Biol Pharm Bull; 1998 Dec; 21(12):1282-5. PubMed ID: 9881639
[TBL] [Abstract][Full Text] [Related]
7. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
Daly TJ; Doten RC; Rusche JR; Auer M
J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
[TBL] [Abstract][Full Text] [Related]
8. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin.
Szebeni A; Mehrotra B; Baumann A; Adam SA; Wingfield PT; Olson MO
Biochemistry; 1997 Apr; 36(13):3941-9. PubMed ID: 9092824
[TBL] [Abstract][Full Text] [Related]
10. DNA-binding sperm proteins with oligo-arginine clusters function as potent activators for egg CK-II.
Ohtsuki K; Nishikawa Y; Saito H; Munakata H; Kato T
FEBS Lett; 1996 Jan; 378(2):115-20. PubMed ID: 8549815
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of backbone cyclic peptides bearing the arm domain of the HIV-1 Rev protein: characterization of the karyophilic properties and inhibition of Rev-induced gene expression.
Hariton-Gazal E; Rosenbluh J; Zakai N; Fridkin G; Brack-Werner R; Wolff H; Devaux C; Gilon C; Loyter A
Biochemistry; 2005 Aug; 44(34):11555-66. PubMed ID: 16114892
[TBL] [Abstract][Full Text] [Related]
12. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
13. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif.
Zapp ML; Hope TJ; Parslow TG; Green MR
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7734-8. PubMed ID: 1715576
[TBL] [Abstract][Full Text] [Related]
14. Interaction of nucleolar protein B23 with peptides related to nuclear localization signals.
Szebeni A; Herrera JE; Olson MO
Biochemistry; 1995 Jun; 34(25):8037-42. PubMed ID: 7794916
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Rev transactivator: a beta-subunit directed substrate and effector of protein kinase CK2.
Meggio F; Marin O; Boschetti M; Sarno S; Pinna LA
Mol Cell Biochem; 2001 Nov; 227(1-2):145-51. PubMed ID: 11827166
[TBL] [Abstract][Full Text] [Related]
16. Site-specific phosphorylation of the human immunodeficiency virus type-1 Rev protein accelerates formation of an efficient RNA-binding conformation.
Fouts DE; True HL; Cengel KA; Celander DW
Biochemistry; 1997 Oct; 36(43):13256-62. PubMed ID: 9341215
[TBL] [Abstract][Full Text] [Related]
17. Helix-loop-helix motif in HIV-1 Rev.
Auer M; Gremlich HU; Seifert JM; Daly TJ; Parslow TG; Casari G; Gstach H
Biochemistry; 1994 Mar; 33(10):2988-96. PubMed ID: 7510518
[TBL] [Abstract][Full Text] [Related]
18. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
West ML; Ramsdale TE
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):85-8. PubMed ID: 9575345
[TBL] [Abstract][Full Text] [Related]
19. Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate.
Cook KS; Fisk GJ; Hauber J; Usman N; Daly TJ; Rusche JR
Nucleic Acids Res; 1991 Apr; 19(7):1577-83. PubMed ID: 2027765
[TBL] [Abstract][Full Text] [Related]
20. In vitro selection of ribozymes dependent on peptides for activity.
Robertson MP; Knudsen SM; Ellington AD
RNA; 2004 Jan; 10(1):114-27. PubMed ID: 14681590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
